Canada
· Delayed Price · Currency is CAD Treatment.com AI Statistics
Total Valuation
Treatment.com AI has a market cap or net worth of CAD 27.92 million. The enterprise value is 26.18 million.
| Market Cap | 27.92M |
| Enterprise Value | 26.18M |
Important Dates
The last earnings date was Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Treatment.com AI has 48.99 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 48.99M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +437.87% |
| Owned by Insiders (%) | 9.95% |
| Owned by Institutions (%) | n/a |
| Float | 43.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 178.29 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.03 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.54 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -221.31% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.80% in the last 52 weeks. The beta is -0.45, so Treatment.com AI's price volatility has been lower than the market average.
| Beta (5Y) | -0.45 |
| 52-Week Price Change | +9.80% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 37.96 |
| Average Volume (20 Days) | 163,203 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Treatment.com AI had revenue of CAD 38,136 and -2.01 million in losses. Loss per share was -0.17.
| Revenue | 38,136 |
| Gross Profit | 24,190 |
| Operating Income | -1.94M |
| Pretax Income | -2.01M |
| Net Income | -2.01M |
| EBITDA | n/a |
| EBIT | -1.94M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 897,393 in cash and 609,171 in debt, giving a net cash position of 288,222 or 0.01 per share.
| Cash & Cash Equivalents | 897,393 |
| Total Debt | 609,171 |
| Net Cash | 288,222 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | -665,178 |
| Book Value Per Share | -0.02 |
| Working Capital | -665,178 |
Cash Flow
| Operating Cash Flow | -199,965 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 63.43% |
| Operating Margin | -5,080.20% |
| Pretax Margin | -5,268.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Treatment.com AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.95% |
| Shareholder Yield | -78.95% |
| Earnings Yield | -29.55% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Treatment.com AI has an Altman Z-Score of -39.52. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -39.52 |
| Piotroski F-Score | n/a |